TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 NOK)
Closing information | 2024/09 | 2023/09 | 2022/09 |
Turnover |
6,479
|
5,855 | |
Financial expenses |
0
|
339 | |
Earnings before taxes |
4,498
|
3,626 | |
EBITDA |
4,104
|
1,894 | |
Total assets |
21,798
|
17,460 | |
Current assets |
8,493
|
7,605 | |
Current liabilities |
2,805
|
1,838 | |
Equity capital |
18,669
|
14,732 | |
- share capital |
49
|
48 | |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2024/09 | 2023/09 | 2022/09 |
Solvency |
85.6%
|
84.4% | |
Turnover per employee |
3,240
|
2,928 | |
Profit as a percentage of turnover |
69.4%
|
61.9% | |
Return on assets (ROA) |
20.6%
|
22.7% | |
Current ratio |
302.8%
|
413.8% | |
Return on equity (ROE) |
24.1%
|
24.6% | |
Change turnover |
493
|
1,200 | |
Change turnover % |
-12%
|
8%
|
26% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/09 | 2023/09 | 2022/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.